Differences in the toxicity of cerium dioxide nanomaterials after inhalation can be explained by lung deposition, animal species and nanoforms by Dekkers, Susan et al.
 
 
University of Birmingham
Differences in the toxicity of cerium dioxide
nanomaterials after inhalation can be explained by
lung deposition, animal species and nanoforms
Dekkers, Susan; Ma-Hock, Lan; Lynch, Iseult; Russ, Mike; Miller, Mark R.; Schins, Roel P.F.;
Keller, Jana; Römer, Isabella; Küttler, Karin; Strauss, Volker; De Jong, Wim H.; Landsiedel,
Robert; Cassee, Flemming R.
DOI:
10.1080/08958378.2018.1516834
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Dekkers, S, Ma-Hock, L, Lynch, I, Russ, M, Miller, MR, Schins, RPF, Keller, J, Römer, I, Küttler, K, Strauss, V,
De Jong, WH, Landsiedel, R & Cassee, FR 2018, 'Differences in the toxicity of cerium dioxide nanomaterials
after inhalation can be explained by lung deposition, animal species and nanoforms', Inhalation Toxicology.
https://doi.org/10.1080/08958378.2018.1516834
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility 03/01/2019
“This is an Accepted Manuscript of an article published by Taylor & Francis in Inhalation Toxicology on 4 Oct 2018, available online:
http://www.tandfonline.com/doi/full/10.1080/08958378.2018.1516834
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
For Peer Review Only
 
 
 
 
 
 
Differences in the Toxicity of Cerium Dioxide Nanomaterials 
after Inhalation can be explained by Lung Deposition, 
Animal Species and Nanoforms. 
 
 
Journal: Inhalation Toxicology 
Manuscript ID UIHT-2018-0045.R2 
Manuscript Type: Research Article 
Date Submitted by the Author: 15-Aug-2018 
Complete List of Authors: Dekkers, Susan; Rijksinstituut voor Volksgezondheid en Milieu,  
Ma-Hock, Lan; BASF,  
Lynch, Iseult; University of Birmingham School of Geography Earth and 
Environmental Sciences 
Russ, Mike; Promethean Particles Ltd 
Miller, Mark; University of Edinburgh Centre for Cardiovascular Science 
Schins, Roel; Institut für Umweltmedizinische Forschung,  
Keller, Jana; BASF, Toxicology and Ecology 
Römer, Isabella; University of Birmingham School of Geography Earth and 
Environmental Sciences 
Küttler, Karin; BASF, Toxicology and Ecology 
Strauss, Volker; BASF SE, Experimental Toxicology and Ecology 
De Jong, Wim; Rijksinstituut voor Volksgezondheid en Milieu 
LANDSIEDEL, Robert; BASF, Toxicology and Ecology 
Cassee, Flemming; National Institute for Public Health and the 
Environment (RIVM) , Centre for Sustainability, Environmental Health 
Research; Universiteit Utrecht IRAS 
  
 
URL: http:/mc.manuscriptcentral.com/uiht
Inhalation Toxicology
For Peer Review Only
 
Page 1 of 52
URL: http:/mc.manuscriptcentral.com/uiht
Inhalation Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
1 
 
Differences in the Toxicity of Cerium Dioxide Nanomaterials after Inhalation 
can be explained by Lung Deposition, Animal Species and Nanoforms.   
Susan Dekkers
a
, Lan Ma-Hock
b
, Iseult Lynch
c
, Mike Russ
d
, Mark R. Miller
e
, Roel 
P.F. Schins
f
, Jana Keller
b
, Isabella Römer
c
, Karin Küttler
b
, Volker Strauss
b
, Wim 
H. De Jong
a
, Robert Landsiedel
b
, Flemming R. Cassee
a,g
.  
 
a
 National Institute for Public Health and the Environment, Bilthoven, The Netherlands 
b
 Experimental Toxicology and Ecology, BASF SE, Ludwigshafen, Germany 
c
 School of Geography, Earth and Environmental Sciences, University of Birmingham, 
Edgbaston, UK 
d
 Promethean Particles Ltd., Nottingham, UK; 
e
 Centre for Cardiovascular Sci nce, University of Edinburgh, Edinburgh, UK;  
f
 IUF – Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany 
g
 Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands 
 
Corresponding author: susan.dekkers@rivm.nl  
This work was supported by the European Union’s Seventh Framework Programme for research, 
technology development and demonstration under grant agreement n° 310451 (NanoMILE) and the 
Netherlands Food and Consumer Product Safety Authority (NVWA).  
Word count: 9316  
Number of figures: 7 
Number of tables: 5  
  
Page 2 of 52
URL: http:/mc.manuscriptcentral.com/uiht
Inhalation Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
2 
 
Differences in the Toxicity of Cerium Dioxide Nanomaterials after Inhalation 
can be explained by Differences in Lung Deposition, Animal Species and 
Nanoforms.   
Considerable differences in pulmonary responses have been observed in animals exposed 
to cerium dioxide nanoparticles via inhalation. These differences in pulmonary toxicity 
might be explained by differences in lung deposition, species susceptibility or 
physicochemical characteristics of the tested cerium dioxide nanoforms (i.e. same chemical 
substance, different size, shape, surface area or surface chemistry). In order to distinguish 
the relative importance of these different influencing factors, we performed a detailed 
analysis of the data from several inhalation studies with different exposure durations, 
species and nanoforms, namely published data on NM211 and NM212 (JRC repository), 
NanoAmor (commercially available) and our published and unpublished data on PROM 
(industry provided). Data were analyzed by comparing the observed pulmonary responses 
at similar external and internal dose levels. Our analyses confirm that rats are more 
sensitive to developing pulmonary inflammation compared to mice. The observed 
differences in responses do not result purely from differences in the delivered and retained 
doses (expressed in particle mass as well as surface area). In addition, the different 
nanoforms assessed showed differences in toxic potency likely due to differences in their 
physicochemical parameters. Primary particle and aggregate/agglomerate size distributions 
have a substantial impact on the deposited dose and consequently on the pulmonary 
response. However, in our evaluation size could not fully explain the difference observed 
in the analyzed studies indicating that the pulmonary response also depends on other 
physicochemical characteristics of the particles. It remains to be determined to what extent 
these findings can be generalized to other poorly soluble nanomaterials. 
Keywords: cerium dioxide; nanomaterial; species differences; nanoform; inhalation; 
toxicity; lung deposition 
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Introduction   
The number and variety of nanomaterials is expected to continue to increase because of the 
adaptability of their physicochemical properties to enhance their functionality for many different 
applications. However, manipulating the physicochemical properties of nanomaterials may also 
lead to undesirable behavior and, possibly, harmful effects in those exposed.  A challenge for 
health risk assessment is the rapidly growing variety of nanomaterials and nanoforms 
(nanomaterials of the same chemical substance, but with different physicochemical 
characteristics such as size, shape, surface area and surface chemistry (EC 2017; ECHA 2017)). 
Thus, in recent years there is an increasing interest in strategies to compare assessments across 
different nanoforms, including (Quantitative) Structure Activity Relationships, grouping and 
read-across (Zhang et al. 2012; Stone et al. 2014; Arts et al. 2015; Oomen et al. 2015). A fuller 
understanding of the influence of basic (physicochemical) properties of nanomaterials on their 
potential toxicity is needed for further development, validation and specifically implementation 
of new or revised approaches in health risk assessment (Dekkers et al. 2016).  
Recently, we have investigated the influence of zirconium doping of cerium dioxide 
nanoparticles (CeO2 NPs) on their biodistribution, pulmonary and cardiovascular effects in mice 
following inhalation (Dekkers et al. 2017). Sub-acute (4 weeks) inhalation of the undoped CeO2 
NPs (4 mg/m
3
, 3 hr/d, 5d/w) resulted in minimal pulmonary and cardiovascular effects in mice 4 
weeks post-exposure. Other toxicity studies showed more pronounced effects after exposure to 
CeO2 NPs under similar exposure conditions in rats (Geraets et al. 2012; Gosens et al. 2014; 
Keller et al. 2014; Arts et al. 2016) and mice (Aalapati et al. 2014). Possible explanations for the 
observed differences in toxicity of CeO2 NPs after inhalation are: a) differences in kinetics 
(deposition and clearance) of the CeO2 NPs, b) differences in the susceptibility of mice 
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compared to rats or c) differences in the toxicity of the different nanoforms of CeO2, due to 
differences in certain physicochemical characteristics such as size, shape and surface chemistry.  
The objective of the analysis described in this paper is to investigate which of these possible 
explanations could explain the relatively mild toxicity of the undoped CeO2 NPs observed in 
Dekkers et al. (2017) compared to the more pronounced toxicity observed in other inhalation 
studies.   
The importance of toxicokinetics in interpreting pulmonary responses to inhaled NPs has 
been highlighted by several researchers (Kreyling et al. 2013; Kuempel et al. 2015; Pauluhn 
2017). Previous studies, such as Braakhuis et al. (2016), indicate that the internal dose is more 
predictive of the toxicity of inhaled NPs than the external dose, suggesting that the deposition 
pattern (i.e. the regions of the respiratory tract in which NPs deposit) determines its interaction 
with the lung (e.g. lung lining fluid, cellular membranes and fluids), and the subsequent lung 
clearance and toxicity.  
Differences in the susceptibility of different species have been observed in several 
studies, showing rats to be more susceptible than mice to inhaled TiO2 NPs and carbon black 
(Bermudez et al. 2004; Elder et al. 2005; Warheit et al. 2016). This difference has been attributed 
to differences in the deposition as well as the pulmonary response, especially at concentrations 
where macrophage-mediated clearance is impaired (pulmonary overload conditions) (Bermudez 
et al. 2004; Warheit et al. 2016). Since the occurrence of lung tumors under pulmonary overload 
conditions in rats may not be representative for humans, the use of rats for particle toxicology 
has been criticized (Warheit et al. 2016). Although pulmonary overload generally occurs at 
higher exposure concentrations in mice and other experimental animals, there is no consensus as 
to the most appropriate species to predict particle induced lung toxicity in humans. One major 
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advantage of using mice is the availability of many disease models and relative ease of genetic 
modification to provide mechanistic insight.   
Toxicokinetics and toxicodynamics of inhaled NPs are greatly influenced by their 
physical characteristics, such as the size and density of the primary particles, aggregates or 
agglomerates, as well as by their chemical composition, dissolution rate, surface reactivity, 
shape, charge and hydrophobicity (Nel et al. 2006; Braakhuis et al. 2014; Bakand and Hayes 
2016).  
To investigate the possible explanation(s) for the discrepancies between the findings of 
different CeO2 NP inhalation studies, we have compared the results of exposure to undoped 
CeO2 NPs (herein referred to as PROM) from our recent study (Dekkers et al., 2017) to the 
results of other 4 week inhalation studies with various nanoforms of CeO2 (referred to as 
NM212, NM211 and NanoAmor in the subsequent tables and figures) in rats and mice (Geraets 
et al. 2012; Aalapati et al. 2014; Gosens et al. 2014; Keller et al. 2014). To investigate species 
differences in the susceptibility to CeO2 NPs, two additional 5 day inhalation studies using the 
same undoped CeO2 NPs as used in Dekkers et al. (2017) (PROM) were performed; one in rats 
and one in mice to bridge the results from the various studies.  These additional studies are not 
presently published in peer-reviewed journals, but were performed within the NanoMILE project 
(http://nanomile.eu-vri.eu/) under GLP according a short term inhalation study (STIS) protocol, 
and were included in Deliverable D7.2 (NanoMILE 2017) which is available upon request. The 
STIS has been specifically designed for the testing of toxicity and kinetics of nanomaterials and 
has previously been applied for hazard assessment of 13 metal oxide nanomaterials, including 
the CeO2 nanoforms NM211 and NM212 (Keller et al. 2014; Landsiedel et al. 2014).   
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To investigate the origin of the differences in toxicity of the different CeO2 nanoforms, 
the results of these 5-day inhalation studies with the PROM CeO2 NPs were compared to the 
results of previous 5 day inhalation studies with other nanoforms of CeO2 (NM212 and NM211) 
in rats (Keller et al. 2014).  
This paper describes the analysis of data from the aforementioned CeO2 NP inhalation 
studies to investigate to what extent the observed differences in toxicity between various studies 
can be explained by differences in kinetics (section 3), species susceptibility (section 4) and/or  
physicochemical characteristics of the nanoforms (section 5).  
We hypothesized that a lower internal dose and higher clearance of the CeO2 NPs might 
explain the relatively mild effects observed 4 weeks post-exposure in our recent study (Dekkers 
et al. 2017).  We also hypothesized that, similar to other poorly soluble particles (such as TiO2 
NPs and carbon black), rats would be more susceptible to exposure to CeO2 NPs than mice. 
Lastly, based on the mild toxicity of PROM CeO2 NPs observed in mice, we hypothesized that 
PROM CeO2 NPs would also be less toxic compared to other nanoforms of CeO2 NPs in rats.   
 
Materials and methods 
 
Selection of the Studies 
The selected studies were limited to those where rats or mice were exposed via inhalation 
(either whole body or nose only) and in which the pulmonary toxicity as well as pulmonary dose 
(i.e. lung burden) were determined. Studies in which rats and mice were exposed for 4 weeks as 
well as for 5 days were selected because not all nanoforms of CeO2 were tested in 4 week 
inhalation studies in both species. An overview of the inhalation studies that were analyzed can 
be found in Table 1. A summary of the pulmonary findings of these inhalation studies can be 
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found in Table S1 of the supplementary information, and further details on the 5-day inhalation 
studies with the PROM CeO2 NPs can be found in Table 4 and Annex S2. 
  
From External Concentration to Internal Lung or Pulmonary Burden 
To investigate the role of kinetics in pulmonary toxicity of CeO2 NPs, toxicity data of the studies 
was compared using a) the external exposure concentration, b) the internal retained dose in the 
lung (i.e. the measured lung burden) and c) the predicted internal retained dose in the pulmonary 
or alveolar regions of the lung (i.e. the expected pulmonary burden). In all studies, the rats or 
mice were exposed to CeO2 NPs at concentrations between 0.5 and 25 mg/m
3
 with similar 
particle size distributions (mass median aerodynamic diameter (MMAD) between 0.9 to 2.2 µm). 
The measured lung burden (LB) was calculated from the measured Ce concentrations in 
the lung tissue (typically determined by ICP-MS) and total lung weight. For those studies in 
which no lung and body weights were reported (Aalapati et al. 2014; Keller et al. 2014), an 
estimation of the lung weight was made based on the lung weights of animals of the same strain 
and similar ages.  
 
 [Table 1 near here] 
 
To verify if the different methods used to measure the LB resulted in comparable results, the 
anticipated LB was also estimated using the Multiple-Path Particle Dosimetry Model (MPPD 
V3.04, Applied Research Associates, Inc., https://www.ara.com/products/multiple-path-particle-
dosimetry-model-mppd-v-304). The chosen MPPD airway morphometry model and input data 
used to estimate the retained dose in the lung of the studies can be found in Table S3 of the 
Page 8 of 52
URL: http:/mc.manuscriptcentral.com/uiht
Inhalation Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
8 
 
supplementary information. For all studies the “deposition and clearance” option of the MPPD 
model was used to estimate the tracheobronchial retention (TBR) and the alveolar retention 
(AR). The density of the bulk material of CeO2 (7.215 g/m
3
) was used as input parameter as no 
information is available of the density of CeO2 nanoforms occurring in the aerosols. Default 
settings where used unless stated otherwise.  
The estimated LB was calculated using the following formula:  
	
	( )⁄ = 	
() + ()

	ℎ	()
 
 
The expected pulmonary burden (PB) was expressed as the surface area of the NPs per surface 
area of the pulmonary region of the lung (mm
2
 NP/cm
2
 lung) instead of µg NP/g lung, based on 
the findings of Braakhuis et al. (2016). PB was calculated using the measured LB, the fraction of 
deposition in the alveolar region of the lung (AD), the total deposition in the lung (alveolar 
deposition + tracheobronchial deposition; AD+TBD) (as estimated with the MPPD model), the 
surface area of the NPs (SANP; estimated using the reported BET measurement or calculated 
based on primary particle size) and the surface area of the pulmonary region of the lung (SAPR; 
estimated with the MPPD model). The data used to calculate the PB of the selected studies can 
be found in Table S4 of the supplementary information. The PB was calculated using the 
following formula: 
	( ⁄ ) =

	(#)		
	(%)
((%) + (%))
		 !"	(
)
 "# 	($
)
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To investigate if differences in LB or PB might explain the differences in toxicity, 
bronchoalveolar lavage fluid (BALF) and histopathological analyses of the studies were 
quantitatively compared using the measured exposure concentration (mg NP/m
3
 air), LB (µg 
NP/g lung) and PB (mm
2
 NP/cm
2
 lung). A quantitative comparison of the effects on the BALF 
analyses among the studies was considered appropriate, since all studies used a similar method 
for lung lavage (2 lavages with a similar volume of saline solution). Alveolar histiocytosis 
(accumulation and infiltration of monocytes and macrophages in the pulmonary tissues) and 
increased neutrophil counts in BALF were also plotted against the exposure concentration, LB 
and PB to further examine dose response relationships, as these parameters were observed in 
most studies and are frequently identified as first evidence of adversity (Pauluhn 2017). 
 
Differences in Susceptibility 
To investigate species differences in susceptibility to the inflammatory effects induced by CeO2 
NPs, and differences in toxicity between PROM CeO2 NPs and NM212, data from the two 
additional 5-day inhalation studies with the PROM CeO2 NPs in rats and mice (see Table 4 and 
Annex S2) were compared.   
 
Statistical Analyses 
GraphPad Prism v7.00 (GraphPad Software, San Diego, California, USA) was used to visualize 
and to analyze the data using linear regression analysis of the measured versus the estimated LB 
and non-linear regression analysis (curve-fitting) of the dose response curves using the various 
dose metrics.   
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Results and Discussion 
 
Internal Lung and Pulmonary Burden 
An overview of the measured and estimated LB and expected PB from the selected CeO2 NP 
inhalation studies can be found in Table 2. Expressing the LB relative to the total lung weight 
and PB relative to the total surface area of the lung might lead to an underestimation of the LB 
and PB if exposure to the CeO2 NPs also significantly increase the lung weight and/or the lung 
surface area. However, expressing the absolute LB and PB levels does not allow comparison of 
LB and PB levels of different studies, due to species, strain, age and bodyweight differences of 
the animals. Approximately 9 to18% of the inhaled (mass) dose was predicted to deposit in the 
lungs, of which between 50 and 70% was expected to deposit in the pulmonary region of the 
lung (see Table S4 in the supplementary information). The measured LB was lower than the 
estimated LB at nearly all exposure concentrations. This overestimation of the LB by the MPPD 
models might be due to an underestimation of the clearance rates or an overestimation of the 
deposition. The clearance rates of the MPPD model are based on LB measurements from studies 
in which various strains of rats (F344) and mice (BALB/C and B6C3F1) were exposed to various 
micro- and nanosized particles (TiO2, C60-fullerenes and FexOy) at various concentrations (0.5, 
2, 10 and 20 mg/m
3
), exposure durations (4 h and 13 weeks) and recovery periods (0 and 6 h, 1 
day, and 2, 4, 8, 13, 26 and 52 weeks). The animal strains (Wistar rats, C57Bl/6 J and CD-1 
mice), NPs (CeO2 NPs), concentrations (0.5, 2, 5, 10, 20 and 25 mg/m
3
), exposure duration (5 
days and 4 weeks) and recovery periods (0 days and 3-5 weeks) of the selected studies only 
partly overlap with those on which the clearance rates of the MPPD model are based. Therefore, 
the high LBs estimated by the MPPD model indicate that the clearance rates might have been 
underestimated by the MPPD model, especially for the mice. Additionally, the deposition may 
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have been overestimated. Next to differences in strains, concentrations and exposure durations 
between the selected studies and the studies on which the deposition in the MPPD model is 
based, also other Although strain differences in respiratory tract geometry are taken into account 
in the MPPD model, the model makes assumptions which may have led to an overestimation of 
deposition. For example, the model assumes spherical aerosols, while aerosols of NPs generally 
consist of non-spherical agglomerates of (spherical or nearly-spherical) primary particles, which 
tend to have a lower density than (solid) spherical particles of the same diameter. An 
overestimation of the density might lead to an overestimation of the amount deposited in the 
lungs.  
 
Differences due to Deposition and Clearance  
To investigate to what extent the differences in toxicity may be explained by differences in 
pulmonary deposition and clearance of the CeO2 NPs, the LB and PB of several 4 week 
inhalation studies with various nanoforms of CeO2 (NM211, NM212, PROM and NanoAmor) in 
rats and mice are compared. A comparison of the measured and estimated LB in rats and mice 
after 4 weeks of exposure to CeO2 is presented in Figure 1.  
 
[Table 2 near here] 
[Figure 1 near here] 
 
The measured LB correlated well (R
2
=0.75) with the estimated LB (Figure 1), although this 
correlation was dominated by studies in rats. The measured LB was mostly lower or similar than 
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the estimated LB, except for mice exposed to 2 mg/mm
3
 NanoAmor for which the measured LB 
was approximately 10 times higher than estimated (see black and white dot in Figure 1). There 
was no consistent relationship between the exposure concentration or particle diameter and the 
percentage of clearance (R
2
<0.5; data not shown).  
Subsequently, it was investigated whether the differences in toxicity observed in the 
different 4 week inhalation studies with various nanoforms of CeO2 in rats and mice can be 
explained by differences in toxicokinetics (LB and PB). Therefore, a quantitative comparison 
was performed of the markers for toxicity (BALF and histopathological analyses) using external 
as well as internal concentrations expressed in two different dose metrics (Table 3 and Figure 2). 
All but one study found aggregates of particles and macrophages in the lungs, whereas only one 
study (in which rats were exposed to NM212) demonstrated an increase in the presence of 
eosinophilic material, interpreted to be indicative of cell damage. Granulomatous inflammation, 
indicative of macrophage mediated inflammation, was noted in only two studies (in which rats 
were exposed to NM212 and mice to NanoAmor). More importantly, neutrophilic inflammation 
was observed in all studies. The severity of the pulmonary toxicity (alveolar histiocytosis in 20% 
of the animals) observed in mice 4 weeks post-exposure to PROM CeO2 NPs (Dekkers et al. 
2017) was remarkably less than the severity of the pulmonary toxicity (increase in neutrophils 
and lymphocytes in BALF, alveolar histiocytosis in 100% of the animals and the occurrence of 
eosinophilic granular material, macrophage aggregates with particles and granulomatous 
inflammation) observed in the other 4 week inhalation studies at similar or even lower external 
and internal concentrations (i.e. in rats exposed to NM211 and NM212 and mice exposed to 
NanoAmor). These findings indicate that differences in toxicity cannot be explained by 
differences in toxicokinetics alone. 
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When the toxicological effects were expressed as percentages of neutrophils in the BALF 
at each exposure concentration, non-linear curve fitting did not provide a suitable fit (R
2
=0.57 
and 0.48; Figure 2a). Non-linear curve fitting was improved by plotting % neutrophils against 
internal dose, for the measured LB (R
2
= 0.70 and 0.96; Figure 2c) but not for the PB (R
2
=0.55 
and 0.56; Figure 2e). However, since the LB of the Aalapati study was approximately 10 times 
higher than the estimated LB (Figure 1 and Table 2), the LB and PB of this study could be 
considered as outliers. Without the data of the Aalapati study, the non-linear curve fitting led to 
better goodness of fit values for both the LB (R
2
=0.71 and 0.97) and PB (R
2
=0.75 and 0.71) 
compared to the exposure concentration (R
2
=0.66 and 0.52). Although these curve fitting 
analyses did not indicate whether LB (µg/g lung) or PB (mm
2
/cm
2
) is a better predictor for the 
observed toxicity, they are in line with previous studies that indicated that the internal dose was 
more predictive of the toxicity of inhaled NPs than the external dose (Kreyling et al. 2013; 
Kuempel et al. 2015; Braakhuis et al. 2016; Pauluhn 2017). Nevertheless, the differences in 
toxicity may to some extent also be explained by differences in susceptibility between mice and 
rats exposed to similar internal dose levels and/or  differences in toxicity between the various 
nanoforms of CeO2. 
 
[Figure 2 near here] 
[Table 3 near here] 
 
Difference in Susceptibility between Mice and Rats  
To further investigate differences in the susceptibility of mice compared to rats, two additional 5 
day inhalation studies with the same nanoform of CeO2 (PROM) were performed; one in mice 
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and one in rats. These additional studies are not presently published in peer-reviewed journals, 
but were performed within the NanoMILE project (http://nanomile.eu-vri.eu/) under GLP and 
were included in Deliverable D7.2 which is available upon request (NanoMILE 2017). The study 
design of these additional studies with PROM CeO2 NPs follow the previously performed 5 day 
inhalation studies with NM212 (Keller et al. 2014), but used nose-only exposure instead of 
whole body exposure, to allow better comparison with the 4 week inhalation study with PROM 
CeO2 NPs in mice (Dekkers et al. 2017). Animals were exposed to similar concentrations of 
CeO2 NPs (0.5, 2 and 5 mg/m
3
) with similar particle size distributions (MMAD between 1.0 and 
1.3 µm for rats and between 0.9 and 1.2 µm for mice). A detailed description of these studies can 
be found in Annex S2 of the supplementary information.   
In male Wistar rats, exposure to PROM CeO2 NPs led to changes of several BALF 
parameters, including increased neutrophils, in animals exposed to 2 mg/m³ and 5 mg/m³ CeO2 
NPs (Table 4), the effects of which were still observed 3 weeks post-exposure. At these 
concentrations, the number of neutrophils was also increased in blood, as were blood monocyte 
counts. These findings indicate that inflammation in the lungs was persistent, and was 
accompanied by systemic inflammation. Histopathological findings after the recovery period 
were only observed at 5 mg/m³. The findings were consistent with a retarded lung clearance after 
2 and 5 mg/m³ CeO2 NP exposure.  
In mice, exposure to PROM CeO2 NPs up to 5 mg/m³ did not lead to any significant 
change in clinical pathology parameters in blood and in BALF, or treatment-related adverse 
effects based on histopathology in mice.  These findings were consistent with the higher 
clearance in mice (approximately 30 to 50 % in 3 weeks) compared to rats (approximately 20 to 
35 % in 3 weeks). 
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The measured LB of the two 5 day inhalation studies was much lower than the estimated 
LB, but showed a high correlation with the estimated LB (R
2
=0.93 for rats and R
2
=0.91 for mice; 
Figure 3). The high LBs estimated by the MPPD model indicate that some of the assumptions 
made by the MPPD model may not necessarily reflect the reality for the rats and mice in the 
selected studies and that the assumed clearance rate might have been underestimated by the 
MPPD model, especially in mice. 
 
[Figure 3 near here] 
 
The LB and PB was higher in rats compared to mice, especially 3 weeks post-exposure, an effect 
that is probably due to the higher clearance rates in mice compared to rats. To investigate if the 
modest toxicity of the PROM CeO2 NPs can be explained by the species difference in 
toxicokinetics, a quantitative comparison of pulmonary effect parameters was performed using 
external as well as internal concentrations (Table 4 and Figure 4). Similar to the curve fitting 
analyses of the 4 week inhalation studies (Figure 2c and e), the curve fitting analyses of the 5 day 
inhalation studies with PROM CeO2 NPs in rats and mice (Figure 4c and e) did not indicate 
whether LB (µg/g lung) or PB (mm
2
/cm
2
) is a better predictor for the observed toxicity. The 
differences in internal concentration (LB and PB) cannot fully explain the differences in the 
severity of the toxicological effects, since changes in BALF and adverse histopathological 
effects were observed at lower LB and PB levels in rats compared to mice. Furthermore, the dose 
response curves are steeper in rats compared to mice, indicating PROM CeO2 NPs are more toxic 
to rats compared to mice (see Figure 4). This indicates that besides differences in kinetics 
(resulting in differences in LBs and PBs) between mice and rats, there are other differences in 
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susceptibility between these species. This is in line with outcomes from previous studies in 
which rats tended to be more susceptible to pulmonary inflammation induced by poorly soluble 
particles (Bermudez et al. 2004; Borm et al. 2015; Warheit et al. 2016). There are no in vitro 
studies available that compare the toxicity of CeO2 NPs in mice and rat macrophages. However, 
the sensitivity of rat alveolar macrophages to various NPs has recently been tested in an in vitro 
assay to predict short-term inhalation of NPs. All four CeO2 NPs tested in this study (including 
NM211 and NM212) showed a dose dependent cytotoxicity and were identified as being 
biologically active in rat alveolar macrophages (Wiemann et al. 2016).  
 
[Table 4 near here] 
[Figure 4 near here] 
 
 
Differences due to Different Nanoforms  
To investigate differences in toxicity between the different CeO2 nanoforms , data from all 5 day 
inhalation studies in rats with NM211,  NM212 and PROM were compared using exposure 
concentration, LB and PB and dose matrices. The measured LB was lower than the estimated LB 
but showed a strong correlation (R
2
=0.99, Figure 5). 
 
[Figure 5 near here] 
 
Exposure to PROM CeO2 NPs resulted in relatively high PB levels compared to NM211 and 
NM212 at similar exposure concentrations (Table 5 and Figure 6). This difference in PB in rats 
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is probably caused by differences in clearance, since the measured LB levels and the estimated 
fractions of the inhaled dose deposited in the lung and pulmonary region of the lung were largely 
similar across the different CeO2 nanoforms (see Table S4). Clearance of particles deposited in 
the lungs is known to depend mainly on the dose, size, shape and dissolution rate of primary 
particles and their aggregates and agglomerates (Greim and Ziegler-Skylakakis 2007; Keller et 
al. 2014). Previous studies investigating the influence of particle size on the clearance have either 
found no influence of particle size on clearance (Semmler et al. 2004; Buckley et al. 2017) or a 
slower clearance of smaller particles (Geraets et al. 2012; Keller et al. 2014; Han et al. 2015). 
Indeed, the nanoforms with the smallest primary particle size (PROM: 4.7 nm) seem to have a 
slower clearance than the larger nanoforms (NM211: 12.5 nm and NM212: 40 nm; see Table S4 
and S5 of supplementary information). However, the size of the aerosols has only a modest 
influence on the clearance rate, with the largest aerosols (NM211) showing a slightly higher 
clearance rate at all exposure concentrations compared to nanoforms with a smaller MMAD 
(NM212 and PROM) (see Table S4 and S5 of supplementary information). 
 
[Figure 6 near here] 
  
To investigate if differences in toxicokinetics across the various nanoforms of CeO2 might 
explain the differences in toxicity, a quantitative comparison of parameters measured in BALF as 
well as histopathological analyses were performed using external as well as internal 
concentrations of NM211, NM212 and PROM (Table 5 and Figure 7). Similar to the curve 
fitting analyses of the 4 week inhalation studies (Figure 2c and e) and the 5 day inhalation 
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studies with PROM CeO2 NPs in rats and mice (Figure 4c and e), curve fitting analyses of the 5 
day inhalation studies in rats with the various CeO2 NPs (Figure 7c and e) did not indicate 
whether LB (µg/g lung) or PB (mm
2
/cm
2
) is a better predictor for the observed toxicity. More 
data is needed to investigate the best dose metric. 
Besides differences in toxicokinetics of CeO2 NPs (resulting in differences in LB and PB), 
differences in the toxicodynamics (i.e. toxic potency) of the different nanoforms of CeO2 may 
account for the observed differences in toxicity. Immediately after exposure (day 0) more severe 
changes in BALF parameters and lung histopathology were observed at lower exposure 
concentrations, LB and PB levels of NM211 and NM212 compared to PROM CeO2 NPs (Table 
5).  This indicates that PROM CeO2 NPs are less toxic than NM211 and NM212 when expressed 
as external concentration (mg NP/m
3
 air), internal mass dose (µg NP/g lung), or internal surface 
area dose (mm
2
 NP/cm
2
 lung). Three weeks after exposure, more severe changes in BALF 
parameters and lung histopathology were observed after exposure to PROM CeO2 NPs compared 
to NM212 at certain exposure concentrations (e.g. 5 mg/m
3
) or LBs (60-70 µg NP/g lung). 
However, similar effects on BALF parameters and lung histopathology were observed at similar 
PB levels for all different nanoforms, indicating a similar toxic potency of all nanoforms when 
the dose is expressed as internal surface area (mm
2
 NP/cm
2
 lung).  
 
[Table 5 near here] 
[Figure 7 near here] 
 
When expressed as exposure concentration (mg NP/m
3
 air) or LB (µg NP/g lung) the dose 
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response curves of the percentage of neutrophils in the BALF are steeper for PROM CeO2 NPs 
than for NM212 (see Figure 7a and c), indicating PROM CeO2 NPs are more toxic than NM212 
when the dose is expressed as external concentration or internal mass dose. Conversely, when 
expressed as PB (mm
2
 NP/cm
2
 lung) the dose response curves are steeper for NM212 compared 
to PROM CeO2 NPs 1 day post-exposure (see Figure 7e), indicating NM212 is more acutely 
toxic than PROM CeO2 NPs when the dose is expressed as internal surface area. Non-linear 
curve fitting did not result in a good fit for NM212 at 3 weeks post-exposure (R
2
 = 0.61), which 
makes the comparison between the different nanoforms of CeO2 based on dose response curves 
of the percentage of neutrophils in the BALF 3 weeks post-exposure difficult.   
The observed differences between the different nanoforms of CeO2 may reflect 
differences in physicochemical characteristics such as size, shape, surface chemistry (reactivity 
and charge), dissolution and hydrophobicity of the different nanoforms. Although there are no 
studies available in which the cytotoxicity of the NM212, NM211 and PROM are compared in 
the same in vitro assays, previous studies have shown that differences in physicochemical 
properties such as (primary) particles size, surface reactivity and shape may lead to differences in 
(cyto)toxicity. 
Previous studies indicate that smaller particles, aggregates, agglomerates and aerosols 
result in higher deposition levels in the deep lung and slower clearance rates than larger particles 
(Braakhuis et al. 2014; Peng et al. 2014). In addition, smaller particles have a relatively large 
surface area (for an equivalent mass) available for interaction with the body, and potentially can 
more easily cross barriers or be taken up by macrophages (Nel et al. 2006; Geiser 2010; Arts et 
al. 2015; Bakand and Hayes 2016). These differences in toxicokinetics and toxicodynamics 
generally lead to smaller particles having a more potent pulmonary inflammation (acute and 
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chronic) after inhalation. However, differences in dose response for smaller TiO2 and Ag NPs 
were found to disappear when the dose was expressed as surface area instead of mass 
(Oberdorster et al. 2005; Braakhuis et al. 2014). This is in contrast to the toxicity observed here 
immediately after exposure to CeO2 NPs, which suggests that the nanoforms of CeO2 with the 
smallest primary particle size (PROM) are less toxic compared to those with larger primary 
particle sizes and a similar or larger aggregate/agglomerate size (NM211 and NM212). However, 
the toxicity observed here 3 weeks post-exposure to CeO2 NPs seems to confirm the findings of 
Oberdorster and Braakhuis, since the observed differences in toxicity between the nanoforms of 
CeO2 NP with different primary particle and aggregate/agglomerate sizes seem to decrease when 
the dose is expressed as surface area (mm
2
 NP/cm
2
 lung) instead of mass (mg NP/m
3
 air or µg 
NP/g lung). 
Besides size, surface reactivity may also influence toxicity (Warheit et al. 2007; 
Braakhuis et al. 2014; Peng et al. 2014; Arts et al. 2015; Bakand and Hayes 2016). NPs with a 
higher surface reactivity are generally able to generate more reactive oxygen species (ROS) that 
may lead to oxidative stress and inflammatory responses. CeO2 NPs have been shown to both 
induce ROS and oxidative stress (Lin et al. 2006; Park et al. 2008; Eom and Choi 2009) as well 
as protect against oxidant-induced effects (Xia et al. 2008; Celardo et al. 2011). Gandon et al. 
(2017) showed that NM212 and NM211 had similar reactivity in the Ferric Reduction Ability of 
Serum (FRAS) assay when the dose was expressed as NM surface area. This is in line with our 
findings showing a similar toxicity of NM212 and NM211 at similar external and internal 
concentrations. The reactivity PROM CeO2 NPs is slightly higher than that of NM212 and 
NM211 (see Table S5). Although, this increasing reactivity with decreasing size is consistent 
with the increase of Ce
3+
 atoms on the surface of smaller particles, this higher reactivity is not in 
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line with our findings showing that PROM CeO2 NPs are less toxic compared to NM212 and 
NM211 at similar external and internal concentrations. .  
Previous studies show contradicting results with respect to the influence of particle shape 
on the toxicity of CeO2 NPs. Wang et al. (2015) showed that cube-like and octahedron-like CeO2 
NPs induced higher cytotoxicity and lower anti-oxidative properties compared to rod-like CeO2 
NPs in HepG2 cells. Forest et al. (2017) on the other hand showed that rod-like CeO2 NPs 
produced significantly and dose-dependently enhanced pro-inflammatory and cytotoxicity 
responses in RAW264.7 cells, that were not observed after exposure to cubic/octahedral NPs. 
Our findings cannot be compared to the results of these previous studies, as they didn’t include 
cubic, octahedral or rod-like CeO2 NPs. TEM images of the nanoforms used in the studies 
discussed here showed that the nanoform with the least toxic potency right after exposure 
(PROM) was spherical (Dekkers et al. 2017). Near-spherical NM211 and polyhedral shaped 
NM212 NPs showed similar toxicity. Because these three nanoforms differ in more than one 
physicochemical characteristic (Table S5), it is difficult to determine the influence of each 
individual characteristic on the observed toxicity.  
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Summary and Conclusion  
In the present study we have used data from several inhalation studies in which mice or rats were 
exposed to various nanoforms of CeO2 to investigate to what extent the observed differences in 
toxicity between various studies can be explained by differences in lung deposition, species 
susceptibility and/or physicochemical characteristics of the tested nanoforms. Considerable 
differences in pulmonary response were observed between mice and rats (Table 4) and between 
the various CeO2 nanoforms tested (Table 5). Our evaluations demonstrate that the external 
exposure concentration, and the NP size and chemical composition (CeO2) alone cannot fully 
explain the observed differences in health effects. The level at which an adverse effect starts to 
develop is also dependent on the internal dose, animal species and the specific nanoform. We 
have shown that rats are more sensitive than mice based on both external and internal 
concentrations. These differences do not result purely from differences in the delivered and 
retained doses (expressed in particle mass as well as surface area). In addition, the different 
nanoforms showed differences in toxic potency. Particle size is highly important to this response, 
but also other physicochemical properties of the CeO2 NPs, such as surface reactivity and surface 
shape, may influence the toxicity of the nanoform. Based on these findings we conclude that the 
observed differences in toxicity of the CeO2 NPs in various inhalation studies can be explained 
by differences in kinetics and susceptibility of rats compared to mice and differences in size as 
well as other physicochemical characteristics of the CeO2 NPs. It remains to be determined to 
what extent these findings can be generalized to other poorly soluble nanomaterials.  
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Table S1: Overview of the pulmonary findings (kinetics and effects) 
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Table S4: Data used to calculate the expected pulmonary burden (PB) 
Table S5: Physicochemical characteristics of the CeO2 NPs of the 5 day inhalation studies in rats  
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Table 1: Overview of the selected CeO2 NP inhalation toxicity studies 
Reference 
Strain, species and 
sex of animals 
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e
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g
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3
) 
a
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a
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s)
 
P
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st
-e
x
p
o
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re
 
p
e
ri
o
d
 (
w
e
e
k
s)
 
Keller et al., 2014 Wistar  rat, female NM211 0.45 1.9 ± 2.9 WB 6 5 3 
25.8 2.2 ± 2.4 
Keller et al., 2014 Wistar  rat, female NM212 
0.5 1.4 ± 2.3 
WB 6 5 3 
5.3 1.2 ± 2.1 
25.9 1.0 ± 2.5 
NanoMILE, 2017 Wistar rat, male PROM 
0.57 1.3 ± 2.2 
NO 6 5 3 
2.04 1.2 ± 2.4 
4.85 1.1 ± 1.3 
Keller et al., 2014 Wistar rat, male NM212 
0.48 1.6 ± 2.1 
WB 6 20 5 
5.2 1.3 ± 2.1 
25.6 0.9 ± 2.5 
Geraerts et al., 2012 Wistar rat, male + 
female 
NM211 10.8 1.0 ± 1.8 NO 6 20 4 
Geraerts et al., 2012 Wistar rat, male + 
female 
NM212 19.95 1.2 ± 2.1 NO 6 20 4 
NanoMILE, 2017 
C57BL/6 J mice, 
male 
PROM 
0.54 1.1 ± 2.5 
NO 6 5 3 
2.04 1.1 ± 2.4 
5.04 0.9 ± 3.0 
Dekkers et al., 2017 C57BL/6 J mice, 
female 
PROM 3.98 0.3 ± 1.6
c
 NO 3 20 4 
Aalipati et al., 2014 CD-1 mice, male NanoAmor 2.0 1.4 ± 2.4 NO 6 20 2 and 4 
a
 These aerosol concentrations are rounded to 0.5, 2, 5, 10, 20 and 25 mg/m
3
 in the main text. 
b
 WB = whole body. 
c
 Mass 
median diameter (MMD) instead of MMAD, estimated based on the particle size distributions of the scanning mobility 
particle sizer (SMPS) measurements, assuming spherical aggregation around primary particles of 4.7 nm. , NO = nose only. 
MMAD=mass median aerodynamic diameter., GSD=geometric standard deviation. 
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Table 2: Measured and estimated lung burden and expected pulmonary burden of the selected inhalation studies 
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Lung burden 
0 days after exposure 
(µg/g lung) 
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 Lung burden 
 3 to 5 weeks after 
exposure (µg/g lung) 
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d
 
c
 
M
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a
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u
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d
 
Keller et al., 2014 rat NM211 0.45 5 days 9.8 17 11 6 0.07 5 3 0.04 
   25.8 5 days 9.4 942 522 269 2.8 327 206 2.6 
Keller et al., 2014 rat NM212 0.5 5 days 11.6 23 13 11 0.06 7 5 0.03 
   5.3 5 days 14.3 295 170 96 0.54 96 70 0.47 
   25.9 5 days 16.2 1640 997 510 3.0 647 317 2.3 
NanoMILE, 2017 rat PROM 0.57 5 days 10.3 32 17 11 0.38 8 7 0.3 
   2.04 5 days 10.8 120 71 36 1.4 44 30 1.3 
   4.85 5 days 12.0 310 179 79 2.9 94 63 3.5 
Keller et al., 2014 rat NM212 0.48 4 weeks 10.7 76 33 37 0.22 15 18 0.12 
   5.2 4 weeks 13.1 1005 508 473 2.8 319 444 3.0 
   25.6 4 weeks 17.8 6735 4053 2382 15 3033 1960 14 
Geraerts et al., 2012 rat NM211 10.8 4 weeks 14.8 3281 1494 639 6.8 1177 x x 
 Geraerts et al., 2012 rat NM212 19.9 4 weeks 13.0 5592 2776 1260 4.9 2334 x x 
NanoMILE, 2017 mice PROM 0.54 5 days 10.7 46 29 6 0.23 12 4 0.14 
   2.04 5 days 10.6 183 116 18 0.61 44 9 0.32 
   5.04 5 days 12.8 522 338 60 
e
 2.1 
e 
144 29 0.94 
Dekkers et al., 2017 mice PROM 3.98 4 weeks 11.5 749 341 x x 103 82 3.4 
Aalipati et al., 2014 mice Nano Amor 2.0 4 weeks 9.3 405 171 1353 17 52 615 7.9 
a
 These aerosol concentrations are rounded to 0.5, 2, 5, 10, 20 and 25 mg/m
3
 in the main text. 
b
 Estimated with the MPPD model (deposition only). 
c
 Estimated with the MPPD 
model (deposition and clearance). 
d
 Calculated using the measured lung burden, estimated pulmonary deposition fractions and estimated surface area of the pulmonary 
region of the lung, as described in the materials and methods section. 
e
 Estimated using the measured lung burden 21 days after exposure and the expected clearance (≈50%). 
The measured lung burden 0 days after exposure (of 495 µg/g lung) was considered unreliable, and was probably a preparation artefact (e.g. big bronchus included in the 
sample). x=no data available. 
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Table 3: Comparison of pulmonary effects in rats and mice after 4 weeks of exposure to various CeO2 NPs (NM211, NM212, 
NanoAmor and PROM) 
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difference 
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w
i
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i
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e
s
 
G
r
a
n
u
l
o
m
a
t
o
u
s
 
i
n
f
l
a
m
m
a
t
i
o
n
 
0-1 days after exposure 
Keller et al. 2014 
 
NM-212 rats 0.48 37 0.22 - 2.3% 100% - + - 
NM-212 rats 5.2 473 2.8 
increased TC, NEU, 
LYM and MON 
49% 100% + + - 
NM-212 rats 25.6 2382 15 
increased TC, NEU, 
LYM and MON 
75% 100% + + - 
Gerearts et al., 2012; 
Gosens et al., 2013 
NM-211 rats 10.8 639 6.8 
increased TC, NEU, 
LYM and MAC 
36% 100% - + - 
NM-212 rats 19.9 1260 4.9 
increased TC, NEU, 
LYM and MAC 
31% 100% - + - 
Aalapati et al., 2013 NanoAmor mice 2.0 1353 17 
increased TC, NEU, 
LYM and MAC 
74% 100% - + + 
3-5 weeks post-exposure 
Keller et al. 2014 
NM-212 rats 0.48 18 0.12 - 4% 0% - + - 
NM-212 rats 5.2 444 3.0 
increased NEU, 
LYM and MON 
43% 100% + + - 
NM-212 rats 25.6 1960 14 
increased TC, NEU, 
LYM and MON 
73% 100% + + + 
Dekkers et al., 2017 PROM mice 4.0 82 3.4 - 1.1% 20% - - - 
Aalapati et al., 2013 NanoAmor mice 2.0 615 7.9 
increased NEU, 
LYM and MAC 
48% 100% - + + 
a
 These aerosol concentrations are rounded to 0.5, 2, 5, 10, 20 and 25 mg/m
3
 in the main text. 
b
 Calculated using the measured lung burden, estimated pulmonary deposition 
fractions and an estimated surface area of the pulmonary region of the lung, as described in the materials and methods section. TC=total cell count, NEU=neutrophils, 
LYM=lymphocytes, MON=monocytes, MAC=macrophages, +=increased incidence compared to the controls, -=no increased incidence compared to the controls. 
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Table 4: Comparison of effects in rats and mice after 5 day exposure to the same CeO2 NPs (PROM) 
Reference N
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p
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0 days after exposure 
NanoMILE, 2017 PROM mice 1.1 2.5 0.54 6.2 0.23 - 0.1% 0% - + 
NanoMILE, 2017 PROM rats 1.3 2.2 0.57 11 0.38 - 5% 0% - + 
NanoMILE, 2017 PROM mice 1.1 2.4 2.04 18 0.61 - 0% 0% - + 
NanoMILE, 2017 PROM rats 1.2 2.4 2.04 36 1.4 increased TC and NEU 7% 0% - + 
NanoMILE, 2017 PROM mice 0.9 3.0 5.04 60
c 
2.1
c
 - 0.1% 0% - + 
NanoMILE, 2017 PROM rats 1.1 2.3 4.85 79 2.9 increased TC, NEU, MON and EPI 29% 0% - + 
3 weeks after exposure 
NanoMILE, 2017 PROM mice 1.1 2.5 0.54 4.2 0.14 - 0.2% 0% - + 
NanoMILE, 2017 PROM rats 1.3 2.2 0.57 7.1 0.30 - 2% 0% - + 
NanoMILE, 2017 PROM mice 1.1 2.4 2.04 9.2 0.32 - 0.2% 0% - + 
NanoMILE, 2017 PROM rats 1.2 2.4 2.04 30 1.3 increased TC and MON 9% 20% - + 
NanoMILE, 2017 PROM mice 0.9 3.0 5.04 29 0.94 - 0.7% 0% - + 
NanoMILE, 2017 PROM rats 1.1 2.3 4.85 63 3.5 increased TC, NEU, MON, LYM and MAC 50% 100% + + 
a
 These aerosol concentrations are rounded to 0.5, 2 and 5 mg/m
3
 in the main text. 
b
 Calculated using the measured lung burden, estimated pulmonary deposition fractions and 
an estimated surface area of the pulmonary region of the lung, as described in the materials and methods section. 
c
 Estimated using the measured lung burden 21 days after 
exposure and the expected clearance based on other dose levels (≈50%). The measured lung burden 0 days after exposure (of 495 µg/g lung) was considered unreliable, and 
was probably a preparation artefact (e.g. big bronchus included in the sample). TC=total cell count, NEU=neutrophils, LYM=lymphocytes, MON=monocytes, 
MAC=macrophages, +=increased incidence compared to the controls, -=no increased incidence compared to the controls. 
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Table 5: Comparison of effects in rats after 5 day exposure to various CeO2 NPs (NM211, NM212 and PROM) 
Reference N
a
n
o
f
o
r
m
 
o
f
 
C
e
O
2
 
N
P
 
M
e
a
s
u
r
e
d
 
e
x
p
o
s
u
r
e
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(
m
g
/
m
3
)
 
 
a
 
L
u
n
g
 
b
u
r
d
e
n
 
 
(
µ
µ µ
µ
g
/
g
 
l
u
n
g
)
 
P
u
l
m
o
n
a
r
y
 
b
u
r
d
e
n
 
(
m
m
2
/
c
m
2
 
l
u
n
g
)
 
b
 
BALF analysis  
(statistically significant difference 
compared to the controls) N
e
u
t
r
o
p
h
i
l
s
 
i
n
 
B
A
L
 
 
(
%
 
t
o
t
a
l
 
c
e
l
l
s
)
 
A
l
v
e
o
l
a
r
 
h
i
s
t
i
o
c
y
t
o
s
i
s
 
 
(
%
 
o
f
 
a
n
i
m
a
l
s
)
 
E
o
s
i
n
o
p
h
i
l
i
c
 
g
r
a
n
u
l
a
r
 
m
a
t
e
r
i
a
l
 
M
a
c
r
o
p
h
a
g
e
 
a
g
g
r
e
g
a
t
e
s
 
w
i
t
h
 
p
a
r
t
i
c
l
e
s
 
0 days after exposure 
Keller et al. 2014 NM211 0.45 5.8 0.07 increased NEU 6.2% 0% - + 
Keller et al. 2014 NM211 25.8 270 2.8 increased TC, NEU, LYM and MON 79% 100% + + 
Keller et al. 2014 NM212 0.5 11 0.06 increased NEU 5% 0% - + 
Keller et al. 2014 NM212 5.3 96 0.54 increased TC, NEU, LYM and MON 50% 0% - + 
Keller et al. 2014 NM212 25.9 510 3.0 increased  TC, NEU and LYM and MON  81% 100% + + 
NanoMILE, 2017 PROM 0.57 11 0.38 - 5.4% 0% - + 
NanoMILE, 2017 PROM 2.04 36 1.4 increased TC and NEU 6.5% 0% - + 
NanoMILE, 2017 PROM 4.85 79 2.9 increased TC, NEU, MON and EPI 29% 0% - + 
3 weeks after exposure 
Keller et al. 2014 NM211 0.45 3.0 0.04 increased NEU 4.8% 0% - + 
Keller et al. 2014 NM211 25.8 206 2.6 increased NEU and LYM 31% 80% - + 
Keller et al. 2014 NM212 0.5 4.8 0.03 - 3% 0% - + 
Keller et al. 2014 NM212 5.3 70 0.47 -  12% 60% - + 
Keller et al. 2014 NM212 25.9 318 2.3 increased NEU 10% 80% - + 
NanoMILE, 2017 PROM 0.57 7.1 0.30 - 2% 0% - + 
NanoMILE, 2017 PROM 2.04 30 1.3 increased TC and MON 9% 20% - + 
NanoMILE, 2017 PROM 4.85 63 3.5 increased TC, NEU, MON, LYM and MAC 50% 100% + + 
a
 These aerosol concentrations are rounded to 0.5, 2 and 5 mg/m
3
 in the main text. 
b
 Calculated using the measured lung burden, estimated pulmonary deposition fractions and an 
estimated surface area of the pulmonary region of the lung, as described in the materials and methods section. TC=total cell count, NEU=neutrophils, LYM=lymphocytes, 
MON=monocytes, MAC=macrophages, +=increased incidence compared to the controls, -=no increased incidence compared to the controls. 
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Figure captions  
 
Figure 1:  Measured lung burden plotted against the estimated lung burden in rats and mice after 
4 weeks of exposure to various CeO2 NPs (NM211, NM212, PROM and NanoAmor). The 
estimated lung burden was assessed using the MPPD V3.04 model.  
Figure 2:  The percentage of neutrophils in the BALF (a, c, and e) and the percentage of animals 
with alveolar histiocytosis (b, d, and f) after 4 weeks of exposure to various CeO2 NPs plotted 
against the measured exposure concentration (mg NP/m
3
 air) (a and b), lung burden (µg NP/g 
lung) (c and d) and expected pulmonary burden (mm
2
 NP/cm
2
 lung) (e and f).  Data from all 4 
week inhalation studies in rats and mice with various nanoforms of CeO2 (NM211, NM212, 
PROM and NanoAmor, as described in Table 3) were used. 
Figure 3:  Measured lung burden plotted against the estimated lung burden in rats and mice after 
5 days of exposure to PROM CeO2 NPs. The estimated lung burden was determined using the 
MPPD model.  
Figure 4:  The percentage of neutrophils in the BALF (a, c, and e) and the percentage of animals 
with alveolar histiocytosis (b, d, and f) after 5 days of exposure of rats and mice to PROM CeO2 
NPs plotted against the measured exposure concentration (mg NP/m
3
 air) (a and b), lung burden 
(µg NP/g lung) (c and d) and expected pulmonary burden (mm
2
 NP/cm
2
 lung) (e and f).  
Figure 5:  Measured lung burden plotted against the estimated lung burden in rats after 5 days of 
exposure to various CeO2 NPs (NM211, NM212 and PROM). The estimated lung burden was 
determined using the MPPD model.   
Figure 6:  Expected pulmonary burden plotted against the measured exposure concentration in 
rats after 5 days of exposure to various CeO2 NPs. Each bar represents the expected pulmonary 
burden either 1 day (white bars) or 3 weeks (black bars) after exposure to a specific exposure 
concentration of NM211, NM212 or PROM CeO2 NPs.  
Figure 7:  The percentage of neutrophils in the BALF (a, c, and e) and the percentage of animals 
with alveolar histiocytosis (b, d, and f) after 5 days of exposure of rats to various CeO2 NPs 
(NM211, NM212 and PROM) plotted against the measured exposure concentration (mg NP/m
3
 
air) (a and b), lung burden (µg NP/g lung) (c and d) and expected pulmonary burden (mm
2
 
NP/cm
2
 lung) (e and f).  
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Figure 1:  Measured lung burden plotted against the estimated lung burden in rats and mice after 4 weeks of 
exposure to various CeO2 NPs (NM211, NM212, PROM and NanoAmor). The estimated lung burden was 
assessed using the MPPD V3.04 model.  
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Figure 2:  The percentage of neutrophils in the BALF (a, c, and e) and the percentage of animals with 
alveolar histiocytosis (b, d, and f) after 4 weeks of exposure to various CeO2 NPs plotted against the 
measured exposure concentration (mg NP/m3 air) (a and b), lung burden (µg NP/g lung) (c and d) and 
expected pulmonary burden (mm2 NP/cm2 lung) (e and f).  Data from all 4 week inhalation studies in rats 
and mice with various nanoforms of CeO2 (NM211, NM212, PROM and NanoAmor as described in Table 3) 
were used.  
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Figure 3:  Measured lung burden plotted against the estimated lung burden in rats and mice after 5 days of 
exposure to PROM CeO2 NPs. The estimated lung burden was determined using the MPPD model.  
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Figure 4:  The percentage of neutrophils in the BALF (a, c, and e) and the percentage of animals with 
alveolar histiocytosis (b, d, and f) after 5 days of exposure of rats and mice to PROM CeO2 NPs plotted 
against the measured exposure concentration (mg NP/m3 air) (a and b), lung burden (µg NP/g lung) (c and 
d) and expected pulmonary burden (mm2 NP/cm2 lung) (e and f).  
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Figure 5:  Measured lung burden plotted against the estimated lung burden in rats after 5 days of exposure 
to various CeO2 NPs (NM211, NM212 and PROM). The estimated lung burden was determined using the 
MPPD model.    
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Figure 6:  Expected pulmonary burden plotted against the measured exposure concentration in rats after 5 
days of exposure to various CeO2 NPs. Each bar represents the expected pulmonary burden either 1 day 
(white bars) or 3 weeks (black bars) after exposure to a specific exposure concentration of NM211, NM212 
or PROM CeO2 NPs.  
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Figure 7:  The percentage of neutrophils in the BALF (a, c, and e) and the percentage of animals with 
alveolar histiocytosis (b, d, and f) after 5 days of exposure of rats to various CeO2 NPs (NM211, NM212 and 
PROM) plotted against the measured exposure concentration (mg NP/m3 air) (a and b), lung burden (µg 
NP/g lung) (c and d) and expected pulmonary burden (mm2 NP/cm2 lung) (e and f).  
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Table S1: Overview of the pulmonary findings (kinetics and effects) of the selected inhalation studies 
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0-1 days after exposure 
Keller et al. 
2014 
 
NM211 rat 
0.45 5 days 5.8 0.07 increased NEU 6.2 0 - + - 
25.8 5 days 270 2.8 increased TC, NEU, LYM and MON 79 100 + + - 
Keller et al. 
2014 
 
NM212 
rat 
 
0.5 5 days 11 0.06 increased NEU 5 0 - + - 
5.3 5 days 96 0.54 increased TC, NEU, LYM and MON 50 0 - + - 
25.9 5 days 510 3.0 
increased  TC, NEU and LYM and 
MON  
81 100 + + - 
NanoMILE, 
2017 
 
PROM rat 
0.57 5 days 11 0.38 - 5.4 0 - + - 
2.04 5 days 36 1.4 increased TC and NEU 6.5 0 - + - 
4.85 5 days 79 2.9 increased TC, NEU, MON and EPI 29 0 - + - 
NanoMILE, 
2017 
 
PROM mice 
0.54 5 days 6.2 0.23 - 0.1 0 - + - 
2.04 5 days 18 0.61 - 0 0 - + - 
5.04 5 days 60
a 
2.1
a
 - 0.1 0 - + - 
Keller et al. 
2014 
 
NM212 rats 
0.48 4 weeks 37 0.22 - 2.3 100 - + - 
5.2 4 weeks 473 2.8 increased TC, NEU, LYM and MON 49 100 + + - 
25.6 4 weeks 2382 15 increased TC, NEU, LYM and MON 75 100 + + - 
Gosens et al., 
2013 
NM211 rats 10.8 4 weeks 639 6.8 increased TC, NEU, LYM and MAC 36 100 - + - 
NM212 rats 19.9 4 weeks 1260 4.9 increased TC, NEU, LYM and MAC 31 100 - + - 
Aalapati et al., 
2013 
Nano 
Amor 
mice 2.0 4 weeks 1353 17 increased TC, NEU, LYM and MAC 74 100 - + + 
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3-5 weeks post-exposure 
Keller et al. 
2014 
NM211 rat 
0.45 5 days 3.0 0.04 increased NEU 4.8 0 - + - 
25.8 5 days 206 2.6 increased NEU and LYM 31 80 - + - 
Keller et al. 
2014 
NM212 rat 
0.5 5 days 4.8 0.03 - 3 0 - + - 
5.3 5 days 70 0.47 - 12 60 - + - 
25.9 5 days 318 2.3 increased NEU 10 80 - + - 
NanoMILE, 
2017 
PROM rat 
0.57 5 days 7.1 0.30 - 2 0 - + - 
2.04 5 days 30 1.3 increased TC and MON 9 20 - + - 
4.85 5 days 63 3.5 
increased TC, NEU, MON, LYM 
and MAC 
50 100 + + - 
NanoMILE, 
2017 
PROM mice 
0.54 5 days 4.2 0.14 - 0.2 0 - + - 
2.04 5 days 9.2 0.32 - 0.2 0 - + - 
5.04 5 days 29 0.94 - 0.7 0 - + - 
Keller et al. 
2014 
NM-212 rats 
0.48 4 weeks 18 0.12 - 4 0 - + - 
5.2 4 weeks 444 3.0 increased NEU, LYM and MON 43 100 + + - 
25.6 4 weeks 1960 14 increased TC, NEU, LYM and MON 73 100 + + + 
Dekkers et al., 
2017 
PROM mice 4.0 4 weeks 82 3.4 - 1.1 20 - - - 
Aalapati et al., 
2013 
NanoAm
or 
mice 2.0 4 weeks 615 7.9 increased NEU, LYM and MAC 48 100 - + + 
TC=total cell count, NEU=neutrophils, LYM=lymphocytes, MON=monocytes, MAC=macrophages, +=increased incidence compared to the controls, -=no increased incidence 
compared to the controls.
 a
 Estimated using the measured lung burden 21 days after exposure and the expected clearance (≈50%). The measured lung burden 0 days after 
exposure (of 495 µg/g lung) was considered unreliable, and was probably a preparation artefact (e.g. big bronchus included in the sample)
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Annex S2: Summary of the short term inhalation studies with PROM CeO2 NPs  
S2.1 Study design and exposure 
The study design for these additional studies with PROM CeO2 NPs followed that of previously 
performed 5 day inhalation studies with NM212, but used nose-only exposure instead of whole body 
exposure, to allow better comparison with the 4 week inhalation study with PROM CeO2 NPs in mice as 
reported previously (Dekker et al., 2017). Briefly, male Wistar rats and male C57BL/6 mice were nose-
only exposed to target concentrations of 0.5, 2 and 5 mg/m³ CeO2 NPs in respirable aerosols for 6 hours 
per day, on 5 consecutive days. The actual exposure concentrations were similar for rats (0.57, 2.04 and 
4.85 mg/m3) and mice (0.54, 2.04 and 5.04 mg/m3) with similar particle size distributions (MMAD 
between 1.0 and 1.3 µm for rats and between 0.9 and 1.2 µm for mice; see Table S3). The concurrent 
control group was exposed to clean air only. During the study, the animals were monitored for mortality 
and clinical signs of toxicity. Body weights were determined twice weekly.  Autopsy was performed and 
toxicity parameters were evaluated either 24 hours after the last exposure or after a post-exposure 
recovery period of 3 weeks (see Table S2). Blood was sampled, selected organs were weighed and a 
broad set of organs and tissues were preserved. The respiratory tract was examined histologically in 5 
animals per group. Clinical chemistry parameters, hematology parameters and acute phase proteins 
were examined in blood of the same 5 animals per group for rats and 3 or 5 additional animals per 
group for mice. After blood sampling these animals underwent bronchoalveolar lavage of the left lung.  
Bronchoalveolar lavage fluid (BALF) was examined for cytological and biochemical parameters including 
selected antigens. Lung burdens were determined in 3 additional animals per group for both rats and 
mice.  
 
Table S2: Overview of number of animals per autopsy group 
Species Post-exposure Histopathology 
lung 
Blood sampling BALF Lung burden 
Rat 24 hours 5 animals/group 3 animals/group 
3 weeks 5 animals/group 3 animals/group 
Mice 24 hour 5 animals/group 3 animals/group 3 animals/group 
3 weeks 5 animals/group 5 animals/group 3 animals/group 
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S2.2 Lung burden 
The results of lung burden measured 24 hours after the exposure and after a 3 week recovery period are 
shown in Figures S2.1 and S2.2, in rats and mice, respectively.  
 
 
Figure S2.1: Lung burden after 5 days of exposure to CeO2 NPs 24 hours (blue bars) and 3 
weeks (orange bars) post-exposure in rats. 
 
  
Figure S2.2: Lung burden after 5 days of exposure to CeO2 NPs 24 hours (blue bars) and 3 
weeks (orange bar) post-exposure in mice.  
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Ce could not be detected in the lung of the control animals (detection limit: 0.3 µg per sample). In rats a 
modest clearance was observed in animals exposed to 0.5 mg/m³ CeO2 NPs the after 3 weeks recovery, 
whereas the clearance of 2 and 5 mg/m³ seemed minimal (Figure S2.1). In mice the lung burden was low 
(0.9 & 2.4 µg Ce/lung) in animals exposed to 0.5 mg/m³ and 2 mg/m CeO2 NPs after exposure, whereas 
the mean lung burden in mice exposed to 5 mg/m³ CeO2 NPs was extraordinary high (~69 µg Ce/lung; 
Figure S2.2).  The high value (of 495 µg/g lung) of mice exposed to 5 mg/m3 CeO2 NPs on study day 5 
(last blue bar) was out of range and probably a preparation artefact (e.g. big bronchus included in the 
sample). In the mice exposed to 0.5 and 2 mg/m3 CeO2 NPs a clearance of approximately 50% was 
observed within the 3 weeks recovery period. A similar clearance rate was assumed for mice exposed to 
5 mg/m3 CeO2 NPs.  
 
S2.3 Hematology and clinical chemistry 
No treatment-related effects were observed for hematology or clinical chemistry parameters, except for 
a slight, but statistically significant increase in the absolute neutrophil counts in rats exposed to 2 and 5 
mg/m3 CeO2 NPs after the three weeks recovery period (see NanoMILE Deliverable D7.2), indicating a 
mild systemic inflammation. 
 
S2.4 Bronchoalveolar lavage fluid (BALF) 
A moderate increase in neutrophil counts was found in the BALF of rats exposed to 2 or 5 mg/m3 CeO2 
NPs 24 h after exposure (Figure S2.3). This was associated with higher alkaline phosphatase (ALP) 
activity and cytokine-induced chemoattractant-1 (CINC-1/IL8) levels. ALP is released by neutrophils and 
CINC-1 is a cytokine which attracts neutrophils into the lung tissue. Epithelial cell counts in BALF were 
marginally increased in rats exposed to 5 mg/m3 CeO2 NPs, indicating an effect on the bronchioles. 
There was also in increased monocyte number and in the cytokines osteopontin and macrophage colony 
stimulating factor (M-CSF) in rats exposed to 5 mg/m3 CeO2 NPs. Increased monocyte chemoattractant 
protein-1 (MCP-1) in rats exposed to 2 and 5 mg/m3 CeO2 NPs also indicates that more monocytes and 
macrophages were attracted into the lung. A higher permeability of the capillaries in the alveoli can be 
assumed because of slightly higher total protein levels in BALF of rats exposed to 5 mg/m3 CeO2 NPs. The 
enzyme activities of lactate dehydrogenase (LDH) and γ-glutamyl transferase (GGT) in BALF of rats 
exposed to 2 and 5 mg/m3 CeO2 NPs were only marginally, but statistically significantly, increased.  
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Figure S2.3: Changes in various BALF parameters in rats on study day 5 (24 hours after last 
exposure). Results are presented as x-fold changes compared to concurrent controls. Cell count = 
total cell count, MPH = alveolar macrophage, LYMPH = lymphocyte, PMN = polymorphnuclear 
neutrophilic granulocyte, GGT = γ-Glutamyl-transferase; LDH = Lactate dehydrogenase; ALP = 
Alkaline phosphatase; NAG = β-N-Acetyl glucosaminidase, GGT = γ-Glutamyl-transferase; 
LDH = Lactate dehydrogenase; ALP = Alkaline phosphatase; NAG = β-N-Acetyl 
glucosaminidase, CINC-1/IL-8 = cytokine-induced neutrophil chemoattractant-1; MCP-1 = 
monocyte chemoattractant protein-1; M-CSF = macrophage colony stimulating factor 
 
In the BALF, monocyte cell counts were increased in rats exposed to 2 and 5 mg/m3 CeO2 NPs (Figure 
S2.4). Absolute neutrophil counts were higher in the BALF of rats exposed to 5 mg/m3 CeO2 NPs 3 weeks 
post-exposure compared to 24 hours post-exposure. Lymphocyte counts were also increased in rats 
exposed to 5 mg/m3 CeO2 NPs, indicating an ongoing inflammatory process in the lungs. This was also 
reflected by high levels of MCP-1 in rats exposed to 5 mg/m3 CeO2 NPs. CINC-1/IL-8 levels in rats 
exposed to 5 mg/m3 CeO2 NPs were lower compared to 24 hours post-exposure, but were still raised 
above control levels. The total protein, LDH and GGT levels in BALF of rats exposed to 5 mg/m3 CeO2 NPs 
3 weeks post-exposure were marginally increased compared to the controls, with levels similar to those 
24 hours post-exposure. ALP activity was lower compared to the 24 hours post exposure, but still 
marginally above control levels. 
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Figure S2.4: Changes in various BALF parameters in rats after a three weeks recovery period on 
study day 26. Results are presented as x-fold changes compared to concurrent controls. Cell 
count = total cell count, MPH = alveolar macrophage, LYMPH = lymphocyte, PMN = 
polymorph nuclear neutrophilic granulocyte, GGT = γ-Glutamyl-transferase; LDH = Lactate 
dehydrogenase; ALP = Alkaline phosphatase; NAG = β-N-Acetyl glucosaminidase, GGT = γ-
Glutamyl-transferase; LDH = Lactate dehydrogenase; ALP = Alkaline phosphatase; NAG = β-
N-Acetyl glucosaminidase, CINC-1/IL-8 = cytokine-induced neutrophil chemoattractant-1; 
MCP-1 = monocyte chemoattractant protein-1; M-CSF = macrophage colony stimulating factor 
No treatment-related changes in cytology parameters, enzyme activities or total protein levels in BALF 
were observed in mice. 
 
S2.5 Pathology 
Histopathological finding in the lungs 
In all exposed groups of both rats and mice, characteristic particles, either single or very few, were 
observed in the cytoplasm of alveolar macrophages (histiocytes) or free in the alveoli. These particles 
were considered to represent test substance. They occurred in all animals of all treatment groups, and 
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were still present after the recovery period in all rats exposed to 0.5 mg/m3 CeO2 NPs, in 4 rats exposed 
to 2 mg/m3 CeO2 NPs and all mice of all exposed groups. In rats, the particles were also seen in the 
bronchus-associated lymphoid tissue (BALT) or in macrophages in the BALT in two rats exposed to 0.5 
mg/m3 CeO2 NPs and in all rats exposed to 2 and 5 mg/m
3 CeO2 NPs. Particles were also present in the 
BALT after the recovery period in 3 rats exposed to 0.5 mg/m3 CeO2 NPs and in all rats exposed to 2 and 
5 mg/m3 CeO2 NPs. 
After the recovery period, a minimal alveolar histiocytosis with particles occurred in one rat exposed to 
2 mg/m3 CeO2 NPs and in all rats exposed to 5 mg/m
3 CeO2 NPs. In addition, all rats exposed to 5 mg/m
3 
CeO2 NPs showed very occasional eosinophilic granular material, most probably debris of degraded 
macrophages, free in the alveoli.  
The occurrence of alveolar histiocytosis with particles in the recovery group in combination with the 
occurrence of eosinophilic granular material in rats exposed to 5 mg/m3 CeO2 NPs was regarded to be an 
indicator of an adverse reaction, whereas the occurrence of particles in single histiocytes or in the BALT 
in the lungs was considered non-adverse, as there were no signs of any cytotoxicity. 
Single or very few particles could be noted within single histiocytes in all exposed mice after the 
recovery period. The occurrence of these particles in the lungs was considered to be treatment-related, 
but because there were no signs of an inflammatory response, it was regarded to be non-adverse. 
 
Histopathological findings in the mediastinal and tracheobronchial lymph nodes 
In rats exposed to the 5 mg/m3 CeO2 NPs, single or very few particles were observed in the mediastinal 
lymph node in one animal and in the tracheobronchial lymph nodes in 3 rats. After the recovery period 
single or very few particles were seen in the mediastinal lymph node of one rat exposed to 2 mg/m3 
CeO2 NPs and in 4 rats exposed to 5 mg/m
3 CeO2 NPs, as well as in the tracheobronchial lymph nodes of 
2 rats exposed to 2 mg/m3 CeO2 NPs and in all rats exposed to 5 mg/m
3 CeO2 NPs. In mice, particles 
were seen free in the lymphoid tissue of the tracheobronchial and mediastinal lymph nodes after the 
recovery period, and in one mouse exposed to 2 mg/m³ CeO2 NPs and in one mouse exposed to 5 
mg/m³ CeO2 NPs. Because there was no activation or aggregation of macrophages, the occurrence of 
these particles was regarded to be non-adverse.
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Table S3: Models and data used to calculate the lung burden (LB) or retained dose in the lung in the selected inhalation studies 
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Keller et al., 2014 ASD 270 NM211 
1.9 2.9 0.45 
119 1.89 WB 6 1 0,  21 1.04 1.26 
2.2 2.4 25.8 
Keller et al., 2014 ASD 270 NM212 
1.4 2.3 0.5 
119 1.89 WB 6 1 0, 21 1.04 1.26 1.2 2.1 5.3 
1.0 2.5 25.9 
NanoMILE, 2017 ASD 270 PROM 
1.3 2.2 0.57 
166 1.88 NO 6 1 0, 22 
1.03 1.22 
1.2 2.4 2.04 1.03 1.15 
1.1 2.3 4.85 1.05 1.40 
Keller et al., 2014 ASD 270 NM212 
1.6 2.1 0.48 
119 1.89 WB 6 4 0, 35 1.10 1.26 1.3 2.1 5.2 
0.9 2.5 25.6 
Geraerts et al., 2012 ASD 224 NM211 1.0 1.8 10.8 166 1.49 NO 6 4 0 0.87 - 
Geraerts et al., 2012 ASD 212 NM212 1.2 2.1 19.95 166 1.39 NO 6 4 0 0.73 - 
NanoMILE, 2017 MB6 24 PROM 
1.1 2.5 0.54 
326 0.19 NO 6 1 0, 21 
0.142 0.131 
1.1 2.4 2.04 0.134 0.139 
0.9 3.0 5.04 0.139 0.128 
Dekkers et al., 2017 MB6 20 PROM 0.29 
c
 1.6 3.98 353 0.20 NO 3 4 28  0.158 
Aalipati et al., 2014 MB6 35 Nano Amor 1.4 2.4 2.00 277 0.17 NO 6 4 0, 28 0.160 0.160 
a
 ASD: Asymmetric Sprague Dawley rat, MB6: Mouse B6C3F1;  
b
 WB: whole body, NO: nose only; 
c
 Mass median diameter (MMD) instead of mass median aerodynamic diameter 
(MMAD), estimated based on the particle size distributions of the scanning mobility particle sizer (SMPS) measurements, assuming spherical aggregation around primary 
particles of 4.7 nm. -: no data available 
Page 51 of 52
URL: http:/mc.manuscriptcentral.com/uiht
Inhalation Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Supplementary Information to Differences in the Toxicity of Cerium Dioxide Nanomaterials after Inhalation can 
be explained by Lung Deposition, Animal Species and Nanoforms.  Dekkers et al., 2018. 
Table S4: Data used to calculate the expected pulmonary burden (PB) in the selected inhalation studies 
Reference 
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Keller et al., 
2014 
rat NM211 12.5 
0.45 5 days 9.8 
 
6.1 63 6.0 3.8 
  53 2864 
0.07 0.04 
25.8 5 days 9.4 5.1 54 280 260 2.80 2.60 
Keller et al., 
2014 rat NM212 40 
0.5 5 days 11.6 6.9 59 11 6.0 
 27 2864 
0.06 0.03 
5.3 5 days 14.3 8.1 57 100 88 0.54 0.47 
25.9 5 days 16.2 9.9 61 530 400 3.04 2.29 
NanoMILE, 
2017 rat PROM 4.7 
0.57 5 days 10.3 5.7 55 11 8.7 
69  2860 
0.38 0.30 
2.04 5 days 10.8 6.3 58 38 35 1.36 1.26 
4.85 5 days 12.0 6.8 57 83 87 2.92 3.05 
Keller et al., 
2014 rat NM212 40 
0.48 4 weeks 10.7 6.0 56 41 23 
 27 2864 
0.22 0.12 
5.2 4 weeks 13.1 7.4 57 520 560 2.77 2.99 
25.6 4 weeks 17.8 10.9 61 2650 2470 15.2 14.3 
Geraerts et 
al., 2012 
rat NM211 12.5 10.8 4 weeks 14.8 7.4 50 557 -  64 2612 6.80 - 
Geraerts et 
al., 2012 
rat NM212 40 19.95 4 weeks 13.0 6.4 50 923 -  27 2543 4.88 - 
NanoMILE, 
2017 mice PROM 4.7 
0.54 5 days 10.7 7.2 67 0.9 0.5 
69  470 
0.23 0.14 
2.04 5 days 10.6 7.2 67 2.4 1.3 0.61 0.32 
5.04 5 days 12.8 8.7 68 8.3 3.7 2.15 0.94 
Dekkers et 
al., 2017 
mice PROM 4.7 3.98 4 weeks 11.5 8.0 70 - 13 69  476 - 3.37 
Aalipati et 
al., 2014 
mice 
Nano 
Amor 
45 2.0 4 weeks 9.3 6.1 65 216 98  56 459 17.3 7.86 
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Table S5: Physicochemical characteristics of the CeO2 nanoparticles used in the 5-day inhalation 
studies in rats. 
Characteristic ↓           Nanoform of CeO2 NP→ NM211 NM212 PROM 
Shape near spherical polyhedral spherical 
Primary particle size (nm) 12.5 40 4.7 
Surface area (BET: m
2
/g) 64 27 - 
Surface reactivity (nmol TEU/m
2 
NP)
a
 14 ± 0.7 13 ± 0.6 17 ± 03 
Charge (mV) 16 42 50 
MMAD (µm) ± GSD at an aerosol conc. of 0.5 mg/m
3
 1.9 ± 2.9 1.4 ± 2.3 1.3 ± 2.2 
MMAD (µm) ± GSD at an aerosol conc. of 2 mg/m
3 - - 1.2 ± 2.4 
MMAD (µm) ± GSD at an aerosol conc. of 5 mg/m
3 - 1.2 ± 2.1 1.1 ± 2.3 
MMAD (µm) ± GSD at an aerosol conc. of 25 mg/m
3 2.2 ± 2.4 1.0 ± 2.5 - 
a
 The surface reactivity was measured with the ferric reduction ability of serum (FRAS) assay (Gandon et al., 2017). The read-out 
of the FRAS assay is calibrated by a concentration series of Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, a 
Vitamin E analogon) and the result expressed as nmol Trolox Equivalent Unites (TEU)/m
2
NP.  
BET= Brunauer, Emmett and Teller method to measure surface area, MMAD=mass median aerodynamic diameter, 
GSD=geometric standard deviation, -: no data available 
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